Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  2001-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0091-3057(01)00644-XPMID 11796155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Donepezil for the treatment of psychosis in dementia with Lewy bodies

  2000cited by this paper
• Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome.

  2000cited by this paper
• Human post-mortem striatal α4β2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome

  2000cited by this paper
• Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer's disease.

  2000cited by this paper
• Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.

  2000cited by this paper
• Neuronal nicotinic receptors in the human brain.

  2000cited by this paper
• Delusions associated with elevated muscarinic binding in dementia with Lewy bodies

  2000cited by this paper
• Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease.

  1999cited by this paper
• Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain.

  1999cited by this paper
• Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia

  1999cited by this paper
• Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain.

  1999cited by this paper
• Intravenous levodopa in hallucinating Parkinson's disease patients

  1998cited by this paper
• Donepezil for Treatment of Dementia With Lewy Bodies: A Case Series of Nine Patients

  1998cited by this paper
• Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.

  1998cited by this paper
• Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease.

  1998cited by this paper
• Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use.

  1998cited by this paper
• Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease

  1998cited by this paper
• Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice

  1998cited by this paper
• Activation of visuomotor systems during visually guided movements: a functional MRI study.

  1998cited by this paper
• Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease

  1998cited by this paper
• A Prospective Study of Psychotic Symptoms in Dementia Sufferers: Psychosis in Dementia

  1997cited by this paper
• Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus.

  1997cited by this paper
• The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies

  1997cited by this paper
• Nicotinic receptor function in schizophrenia.

  1996cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• DELUSIONS AND HALLUCINATIONS IN ALZHEIMER'S DISEASE: RESULTS FROM A TWO‐YEAR LONGITUDINAL STUDY

  1996cited by this paper
• Cholinesterase inhibition in Parkinson's disease.

  1996cited by this paper
• Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease.

  1996cited by this paper
• Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness.

  1995cited by this paper
• Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia.

  1995cited by this paper
• Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.

  1995cited by this paper
• Neuroleptic sensitivity to risperidone in Lewy body dementia.

  1995cited by this paper
• The prevalence and phenomenology of psychotic symptoms in dementia sufferers

  1995cited by this paper
• Hallucinations in Parkinson's disease: Characteristics and associated clinical features

  1995cited by this paper
• Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease.

  1994cited by this paper
• A Study of Delusions in a Large Cohort of Alzheimer's Disease Patients.

  1994cited by this paper
• Lewy bodies and response to tacrine in Alzheimer's disease.

  1994cited by this paper
• Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerized tomography findings

  1993cited by this paper
• Alzheimer's disease: the burden of the illness in England.

  1993cited by this paper
• Computerized diagnosis from a standardized history schedule: A preliminary communication about the organic section of the HAS–AGECAT system

  1992cited by this paper
• Neuroleptic sensitivity in patients with senile dementia of Lewy body type.

  1992cited by this paper
• The fall and rise of neuronal alpha-bungarotoxin binding proteins.

  1992cited by this paper
• The fall and rise of neuronal α-bungarotoxin binding proteins

  1992cited by this paper
• The Columbia University Scale for Psychopathology in Alzheimer's disease.

  1992cited by this paper
• Hallucinations and associated factors in Alzheimer's disease.

  1991cited by this paper
• Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease.

  1991cited by this paper
• Nucleus basalis lesions decrease alpha- and kappa-bungarotoxins binding in rat cortex.

  1991cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Psychiatric, neurological and medical aspects of misidentification syndromes: a review of 260 cases

  1991cited by this paper
• Neuropathologic and neurochemical correlates of psychosis in primary dementia.

  1991cited by this paper
• Psychiatric Phenomena in Alzheimer's Disease. I: Disorders of Thought Content

  1990cited by this paper
• Caregiving and the stress process: an overview of concepts and their measures.

  1990cited by this paper
• Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

  1990cited by this paper
• Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types

  1990cited by this paper
• Senile dementia of Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

  1990cited by this paper
• Evidence of a Monoaminergic‐Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body Dementia

  1990cited by this paper
• Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type.

  1989cited by this paper
• CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia

  1986cited by this paper
• Symptoms of mental impairment among elderly adults and their effects on family caregivers.

  1986cited by this paper
• Dementia: A Clinical Approach

  1983cited by this paper
• The impact of dementia on the family.

  1982cited by this paper

• The cholinergic system in dementia with Lewy bodies.

  2025cites this paper
• Neuromodulation of excitation-inhibition balance in dementia with lewy bodies: a translational framework.

  2025cites this paper
• Cholinergic Antagonists and Behavioral Disturbances in Neurodegenerative Diseases

  2023cites this paper
• Phantom vision after eye removal: prevalence, features and related risk factors

  2021cites this paper
• Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management

  2020cites this paper
• Therapeutic approaches to cholinergic deficiency in Lewy body diseases

  2020cites this paper
• Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy

  2020cites this paper
• Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation

  2020cites this paper
• The Pharmacology of Visual Hallucinations in Synucleinopathies

  2019cites this paper
• Visual hallucinations, thalamocortical physiology and Lewy Body Disease: A Review.

  2019cites this paper
• Toward personalized treatment of hallucinations

  2018cites this paper
• Assessment of the visual thalamic circuitry in hallucinations in dementia with Lewy bodies

  2017cites this paper
• Cholinergic pathology in dementia with Lewy bodies

  2017cites this paper
• Effect of APOE and CHRNA7 Genotypes on the Cognitive Response to Cholinesterase Inhibitor Treatment at Different Stages of Alzheimer’s Disease

  2015cites this paper
• Therapeutic Potential of α7 Nicotinic Acetylcholine Receptors

  2015cites this paper
• Computational model of visual hallucination in dementia with Lewy bodies

  2015cites this paper
• Visual Hallucinations in Dementia with Lewy Bodies (II): Computational Aspects

  2015cites this paper
• Visual Hallucinations in Dementia with Lewy Bodies (I): A Hodological View

  2015cites this paper
• Treatment at Different Stages of Alzheimer ' s Disease Genotypes on the Cognitive Response to Cholinesterase Inhibitor CHRNA 7 and APOE Effect of

  2014cites this paper
• Predictors of response to acetylcholinesterase inhibitors : an observational case register-based cohort study

  2013cites this paper
• Striatal Dopamine Transporter Binding Does Not Correlate with Clinical Severity in Dementia with Lewy Bodies

  2013cites this paper
• Clinical Trials of Dementia With Lewy Bodies and Parkinson’s Disease Dementia

  2012cites this paper
• Cerebral correlates of psychotic syndromes in neurodegenerative diseases

  2012cites this paper
• Käärmeistä ja merietanoista eristettyjen toksiinien farmakologiset ja terapeuttiset vaikutukset neuronaalisiin nikotiinireseptoreihin

  2010cites this paper
• Degeneration of dementia with Lewy bodies measured by diffusion tensor imaging

  2009cites this paper
• Rivastigmine in Parkinson's disease dementia

  2009cites this paper
• Symptômes comportementaux et psychologiques lors de démence

  2008cites this paper
• Nicotinic α4β2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations

  2008cites this paper
• Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography.

  2007cites this paper
• Distinguishing Lewy body dementias from Alzheimer’s disease

  2007cites this paper
• Dementia with Lewy bodies.

  2007cites this paper
• Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline

  2007cites this paper
• SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile

  2007cites this paper
• Chapter 9 Dementia with Lewy Bodies and Parkinson's Disease Dementia

  2007cites this paper
• A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia.

  2007cites this paper
• Dementia with Lewy bodies.

  2006cites this paper
• Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism.

  2006cites this paper
• [Treatment of dementia with Lewy bodies].

  2006cites this paper
• Prise en charge thérapeutique de la démence à corps de Lewy

  2006cites this paper
• [The neurochemistry and neuropharmacology of diffuse Lewy body disease].

  2006cites this paper
• Involvement of the recurrent artery of Heubner with contralateral middle cerebral artery infarction

  2006cites this paper
• Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies.

  2005cites this paper
• Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations

  2005cites this paper
• Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum.

  2004cites this paper
• Dementia with Lewy bodies: a review.

  2004cites this paper
• Neurochemistry of consciousness: cholinergic pathologies in the human brain.

  2004cites this paper
• Involvement of α6/α3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [125I]-α-conotoxin MII binding in the thalamus and striatum.

  2004cites this paper
• Role of Cholinesterase Inhibitors in Parkinson’s Disease and dementia with Lewy Bodies

  2004cites this paper
• Le corps de Lewy, marqueur abusif de la maladie de Parkinson ?

  2003cites this paper
• Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia.

  2003cites this paper
• Neurotransmitter Correlates of Neuropsychiatric Symptoms in Dementia with Lewy Bodies

  2003cites this paper
• [Lewy bodies, a misleading marker for Parkinson's disease?].

  2003cites this paper
• Use of functional imaging in parkinsonism and dementia

  2003cites this paper
• Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease

  2003cites this paper
• Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia

  2003cites this paper
• Pathology and Neurotransmitter Abnormalities of Dementia with Lewy Bodies

  2003cites this paper
• Clinical predictors of response to acetyl cholinesterase inhibitors: experience from routine clinical use in Newcastle

  2003cites this paper
• Current awareness in geriatric psychiatry.

  2002cites this paper
• Neuroscience and Biobehavioral Reviews

  year unknowncites this paper